Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension. [electronic resource]
- The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation Dec 2008
- 1326-32 p. digital
Publication Type: Journal Article
1557-3117
10.1016/j.healun.2008.08.007 doi
Administration, Inhalation Adult Aged Anticoagulants--therapeutic use Cyclic GMP--blood Cyclic Nucleotide Phosphodiesterases, Type 5--metabolism Diuretics--therapeutic use Female Follow-Up Studies Humans Hypertension, Pulmonary--complications Male Middle Aged Nitric Oxide--administration & dosage Phosphodiesterase 5 Inhibitors Phosphodiesterase Inhibitors--therapeutic use Safety Thromboembolism--complications Treatment Outcome Vasodilator Agents--therapeutic use